Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

類似資料

• The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
  著者:: Kawalec, Paweł, 等
  出版事項: (2016)
• Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
  著者:: Malinowski, Krzysztof Piotr, 等
  出版事項: (2018)
• Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland
  著者:: Kawalec, Paweł, 等
  出版事項: (2016)
• Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland.
  著者:: Ewa Stawowczyk, 等
  出版事項: (2016-01-01)
• Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland
  著者:: Stawowczyk, Ewa, 等
  出版事項: (2016)